Evaluating Tolerability of Elective Pelvic Ultra Hypofractionated Irradiation Treatment (ePUHRT) With High Dose Rate Brachytherapy Boost for Unfavorable and Higher Risk Prostate Cancer
The purpose of this study is to evaluate the tolerability and toxicity of combining two radiation therapy methods for prostate cancer: Elective Pelvic Ultra Hypofractionated Irradiation Treatment (ePUHRT), which is an external beam radiotherapy with High Dose Rate Brachytherapy Boost (form of internal radiation where a cancer doctor implants a small plastic tube or balloon (catheter) in the tumor).
• ≥ 18 years old at the time of informed consent
• Capable of providing informed consent and HIPAA authorization
• Karnofsky performance score ≥ 70
• Pathologically confirmed unfavorable intermediate, high, and very high-risk prostate cancer per treating physician
• Candidate plans to undergo the standard of care prostate high dose brachytherapy boost procedure